Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

Medtech entrepreneur Joe Kiani has been entangled in a proxy battle with activist investors and a lengthy legal dispute with ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.

MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products.

Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after longtime CEO and founder Joe Kiani was ousted in a bitter proxy battle with ...

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her ...

Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief Executive Officer ("CEO") of the ...

Looking ahead to 2025, Masimo projects healthcare revenues to land between $1.5 billion and $1.53 billion. That would deliver ...

Check the time stamp on this data. Updated AI-Generated Signals for Masimo Corporation (MASI) available here: MASI. Type a ...